Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Cyclophosphamide 344Rituximab 307Vincristine 159Doxorubicin 156venetoclax 154Specimen Handling 154fludarabine 153Prednisone 151Biopsy 124Magnetic Resonance Spectroscopy 119obinutuzumab 116Lenalidomide 110Dexamethasone 105Cytarabine 98ibrutinib 96Etoposide 92fludarabine phosphate 87Methotrexate 85acalabrutinib 78Bendamustine Hydrochloride 73zanubrutinib 72blinatumomab 64pembrolizumab 62CT-P10 60Gemcitabine 51Nivolumab 45Calcium Dobesilate 45glofitamab 44Mercaptopurine 44prednylidene 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cytogenetic Analysis × Lymphoid × 1 year × Clear all
NCT00812669 2025-07-08

CLL-Irl Study. CTRIAL-IE (ICORG) 07-01, V7

Cancer Trials Ireland

Phase 2 Completed
52 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡